Abstract. The colliding-wind binary system WR 140 (HD 193793, WC7pd+O4-5, P = 7.94 yr) was monitored in the ultraviolet by IUE from 1979 to 1994 in 35 short-wavelength high-resolution spectra. An absorption-line radial-velocity solution is obtained from the photospheric lines of the O component, by comparison with a single O star. The resulting orbital parameters, e = 0.87 ± 0.05, ω = 31• ± 9• and KO star = 25 ± 15 km s −1 , confirm the large eccentricity of the orbit, within the uncertainties of previous optical studies. This brings the weighted mean UV-optical eccentricity to e = 0.85 ± 0.04. Occultation of the O-star light by the WC wind and the WC+O colliding-wind region results into orbital modulation of the P-Cygni profiles of the C ii, C iv and Si iv resonance lines. Near periastron passage, the absorption troughs of those resonance-line profiles increase abruptly in strength and width, followed by a gradual decrease. In particular, near periastron the blue black-edges of the P-Cygni absorption troughs shift to larger outflow velocities. We discuss that the apparently larger wind velocity and velocity dispersion observed at periastron could be explained by four phenomena: (i) geometrical resonance-line eclipse effects being the main cause of the observed UV spectral variability, enhanced by sightline crossing of the turbulent wind-wind collision zone; (ii) the possibility of an orbital-plane enhanced WC7 stellar wind; (iii) possible common-envelope acceleration by the combined WC and O stellar radiation fields; and (iv) possible enhanced radiatively driven mass loss due to tidal stresses, focused along the orbiting line of centers.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.